Skip to content

ANIXA BIOSCIENCES, INC.

ANIX

CIK 0000715446

← back to feed
Revenue (TTM)
$210K
−59.0% YoY Q2 Jun 2026
Net Income (TTM)
−$10.13M
+13.0% YoY Q2 Jun 2026
EPS Diluted (TTM)
−$0.31
+12.8% YoY Q2 Jun 2026
Gross Margin
86.2%
Q2 Jun 2026
Operating Margin
-5,143.8%
Q2 Jun 2026
Net Margin
-4,823.3%
Q2 Jun 2026
Free Cash Flow (TTM)
−$9.95M
Q2 Jun 2026
Cash
$1.48M
Q2 Jun 2026
Total Debt
$370.18K
Q2 Jun 2026
Shares Outstanding
34.02M sh
Q2 Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings